COVECTRA, a multi-layered brand protection solutions provider offering serialization, authentication, and track and trace technology services, today announced the launch of a new medication adherence program designed to provide substantial benefits to manufacturers, hospitals, pharmacies, and patients, while simultaneously addressing new regulatory guidelines recently established by the FDA. COVECTRA's medication adherence program features a serialization solution, which offers a unique communication channel to improve adherence through early detection & correction of non-adherence. By encouraging timely and accurate dosing of prescribed medications on the part of the patient, the Adherence Program promotes appropriate refills for uninterrupted health care for the duration of the medication regimen.
One-third to one-half of all patients do not take medication as prescribed , and some studies show that approximately 125,000 Americans die each year due to medication non-adherence. Sixty percent of prescription medication non-adherence problems are preventable.
In addition to extensive patient monitoring capabilities, COVECTRA's Adherence Program offers a platform for targeted recalls, and provides extensive data for value mining. This real time data also enables brand representatives the ability to authenticate inventory on the spot. This streamlined technology is designed to simultaneously enhance patient outcomes, improve prescriber confidence, create compelling data for payers that can be quantified into net lifetime benefits, improve the integrity of inventory, and reduce administrative costs. Another important benefit of the COVECTRA Adherence Program is that it can help establish a direct link between the pharma company and the patient, thereby enhancing brand loyalty.
“Poor medication adherence is a serious issue. Non-adherence can lead to increased disease progression, unnecessary and costly hospitalizations, emergency room visits and even death,” stated COVECTRA Director of Brand Integrity Solutions, Terrence O'Neill.
“Our program offers a significantly enhanced level of communication with patients, enabling busy physicians to improve patient monitoring and act as an early warning system of potential non-adherence. Not only does this help drive new prescriptions as program integrity is established with prescribers, but also value is realized as refill rates are reinforced through patient services interaction,” added O'Neill.
Additionally, brand owners can gain visibility into patient treatment through providing additional support of the patient while managing side effects and the other challenges during the healing process. Through COVECTRA's Adherence Program, which utilizes serialization, the overall effectiveness of pharmaceutical manufacturers' patient service programs can be exponentially enhanced.
COVECTRA flagship product, AuthentiTrack £ provides unprecedented capabilities by enabling unique identification down to the unit dose that can be leveraged for complete supply chain visibility, product integrity, and track and trace applications. This technology enables improved communication with patients, supports greater adherence and detection of non-adherence, and provides manufacturers with the opportunity to meet FDA guidelines.
Companies in this article
